Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.
By Carmine Zoccali, S. Bode-Böger, F. Mallamaci, F. Benedetto, Giovanni Tripepi, L. Malatino, A. Cataliotti, I. Bellanuova, I. Fermo, J. Frölich and 1 more. The Lancet, 2001
1,108 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Physiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/c60b40cbf28cd93088088580eb7e19e4f1a59f3a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Physiology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Endothelial dysfunction. (2004, background): “Moreover, it was found to be a predictor of acute coronary events (51), overall mortality of patients with chronic renal failure (52), and mortality of critical ill patients (45).”
- Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. (2003, methodology): “in a situation that can be considered as ‘steady state’ in these patients [46,47], a 1.”
- Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. (2002, neutral): “HDL cholesterol 51 (16) [30-116] 46 (15) [27-94]”